RBM39 degrader invigorates innate immunity to eradicate neuroblastoma despite cancer cell plasticity

70

RBM39 degrader invigorates innate immunity to eradicate neuroblastoma despite cancer cell plasticity

Tags:

Previous Article

‘Creeping fat’ can worsen Crohn’s disease

Combination of RNA splicing factor and immunotherapy to treat neuroblastoma

Related Posts

CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis

CD19-targeted chimeric antigen receptor T cell therapy ...

137

Astrocytic ankyrin-2 enables memory persistence in the mouse hippocampus

Astrocytic ankyrin-2 enables memory persistence in the ...

53

Molecular damage associated with ageing drives inflammation in cardiovascular disease

Molecular damage associated with ageing drives inflamma...

81